These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
424 related articles for article (PubMed ID: 10333319)
1. Bisquinoline antimalarials: their role in malaria chemotherapy. Raynes K Int J Parasitol; 1999 Mar; 29(3):367-79. PubMed ID: 10333319 [TBL] [Abstract][Full Text] [Related]
2. Quinoline antimalarials: mechanisms of action and resistance. Foley M; Tilley L Int J Parasitol; 1997 Feb; 27(2):231-40. PubMed ID: 9088993 [TBL] [Abstract][Full Text] [Related]
3. Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents. Foley M; Tilley L Pharmacol Ther; 1998 Jul; 79(1):55-87. PubMed ID: 9719345 [TBL] [Abstract][Full Text] [Related]
6. Quinoline drug-heme interactions and implications for antimalarial cytostatic versus cytocidal activities. Gorka AP; de Dios A; Roepe PD J Med Chem; 2013 Jul; 56(13):5231-46. PubMed ID: 23586757 [TBL] [Abstract][Full Text] [Related]
7. Involvement of heme in the antimalarial action of chloroquine. Fitch CD Trans Am Clin Climatol Assoc; 1998; 109():97-105; discussion 105-6. PubMed ID: 9601131 [TBL] [Abstract][Full Text] [Related]
8. Ferriprotoporphyrin IX, phospholipids, and the antimalarial actions of quinoline drugs. Fitch CD Life Sci; 2004 Mar; 74(16):1957-72. PubMed ID: 14967191 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of the peroxidative degradation of haem as the basis of action of chloroquine and other quinoline antimalarials. Loria P; Miller S; Foley M; Tilley L Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):363-70. PubMed ID: 10191268 [TBL] [Abstract][Full Text] [Related]
10. The Development of Novel Compounds Against Malaria: Quinolines, Triazolpyridines, Pyrazolopyridines and Pyrazolopyrimidines. C S Pinheiro L; M Feitosa L; O Gandi M; F Silveira F; Boechat N Molecules; 2019 Nov; 24(22):. PubMed ID: 31766184 [TBL] [Abstract][Full Text] [Related]
11. Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum. van Schalkwyk DA; Egan TJ Drug Resist Updat; 2006; 9(4-5):211-26. PubMed ID: 17064951 [TBL] [Abstract][Full Text] [Related]
15. Digestion of the host erythrocyte by malaria parasites is the primary target for quinoline-containing antimalarials. Zarchin S; Krugliak M; Ginsburg H Biochem Pharmacol; 1986 Jul; 35(14):2435-42. PubMed ID: 3524576 [TBL] [Abstract][Full Text] [Related]
16. Theories on malarial pigment formation and quinoline action. Sullivan DJ Int J Parasitol; 2002 Dec; 32(13):1645-53. PubMed ID: 12435449 [TBL] [Abstract][Full Text] [Related]
17. A common mechanism for blockade of heme polymerization by antimalarial quinolines. Sullivan DJ; Matile H; Ridley RG; Goldberg DE J Biol Chem; 1998 Nov; 273(47):31103-7. PubMed ID: 9813011 [TBL] [Abstract][Full Text] [Related]
18. Haematin (haem) polymerization and its inhibition by quinoline antimalarials. Ridley RG; Dorn A; Vippagunta SR; Vennerstrom JL Ann Trop Med Parasitol; 1997 Jul; 91(5):559-66. PubMed ID: 9329993 [TBL] [Abstract][Full Text] [Related]
19. Plasmodium: resistance to antimalarial drugs. Peters W Ann Parasitol Hum Comp; 1990; 65 Suppl 1():103-6. PubMed ID: 2264669 [TBL] [Abstract][Full Text] [Related]